The Clorox Company (NYSE:CLX) Holdings Cut by Mitchell Mcleod Pugh & Williams Inc.

Mitchell Mcleod Pugh & Williams Inc. reduced its stake in shares of The Clorox Company (NYSE:CLX) by 12.6% during the 4th quarter, HoldingsChannel reports. The fund owned 3,942 shares of the company’s stock after selling 567 shares during the period. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Clorox were worth $640,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. Catalyst Capital Advisors LLC acquired a new position in Clorox in the 3rd quarter worth about $54,000. AQR Capital Management LLC grew its stake in shares of Clorox by 8.6% in the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company’s stock valued at $39,121,000 after buying an additional 22,676 shares in the last quarter. Los Angeles Capital Management LLC increased its holdings in Clorox by 5.6% in the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after buying an additional 10,149 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its position in Clorox by 60.5% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company’s stock valued at $3,244,000 after acquiring an additional 8,957 shares in the last quarter. Finally, Canada Pension Plan Investment Board lifted its stake in Clorox by 1.6% in the second quarter. Canada Pension Plan Investment Board now owns 353,394 shares of the company’s stock valued at $48,228,000 after acquiring an additional 5,500 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 0.1 %

CLX opened at $160.31 on Monday. The business has a 50 day moving average of $164.25 and a 200-day moving average of $156.54. The stock has a market capitalization of $19.84 billion, a price-to-earnings ratio of 55.86, a P/E/G ratio of 2.90 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $0.49 EPS. The business’s revenue was up 27.0% on a year-over-year basis. As a group, sell-side analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.04%. Clorox’s dividend payout ratio is 170.04%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several analyst reports. DA Davidson increased their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Evercore ISI lowered their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $155.00 to $157.00 in a research report on Tuesday, January 7th. Barclays lowered their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $156.54.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.